Advocacy in Action: June 2024

Welcome to ASRM's Advocacy in Action, where we give an overview of what our Government Affairs team has been working on, summarize relevant federal and state legislation, and highlight the advocacy and outreach efforts of our members. We are so thankful for the advocacy of our members; please get in touch with the Office of Public Affairs at [email protected] for more information on ways to get involved.

• ASRM members and staff attended the June 12 Senate floor hearing of the IVF for All Act, an omnibus package of bills that would increase access to IVF for all Americans. While we are disappointed that a filibuster prevented the bill package from passing, we are proud of our tireless advocates who came to DC and contacted their representatives to support the cause. ASRM thanks Sens. Tammy Duckworth, Patty Murray, and Cory Booker for introducing this bill package, and Senate Majority Leader Chuck Schumer for bringing it to the Senate floor. Read a statement from Chief Advocacy and Policy Officer Sean Tipton on the bill and its failure to pass here.
• ASRM is proud to support the HOPE with Fertility Services Act (HR 8821), a bipartisan bill that will mandate coverage for fertility treatments under healthcare plans that provide obstetrical coverage. Urge your representatives to VOTE YES on the billusing our Action Alert system.Read our full press release here.
• ASRM CEO Dr. Jared Robins, President Dr. Paula Amato, and delegates Dr. Ginny Ryan, Dr. Albert Hsu, and Dr. Rachel Whynott attended the American Medical Association's House of Delegates meeting to advocate for improved access to care alongside our membership. Their efforts saw the passage of a resolution to oppose any civil or criminal legislation, ballot measures, or court rulings that would equate gametes or embryos with children, or that would otherwise criminalize, restrict or interfere with evidence-based ART care. See a photo from the event here.
• ASRM is thrilled that the Supreme Court has ruled to keep mifepristone, a safe and effective reproductive medicine, legal and accessible to all Americans.Read our joint statement with ACOG in favor of Mifepristone's legality here and our reaction to the Supreme Court's ruling here.
• ASRM's Action Alert challenge is underway! Enter to win by engaging with as many of the Action Alerts we send members via email and socials as possible. Contest ends October 1. For more information on the challenge and how to engage with our Action Alerts, click here.
• June 24 marked the two-year anniversary of the day the Supreme Court overturned Roe v Wade, ignoring the will of most Americans. Since then, we have witnessed attacks on reproductive rights, trans care, and IVF. It's time to fight back. Find out how you can get involved at the state level using our advocacy toolkit.
• Registration is OPEN for ASRM's 2024 Scientific Congress! Sign up here.

Are you interested in making a difference? Fill out this form to share your information and interests for our advocacy effortsand stay involved as we work together to create a brighter future.

If you would like to support us in our fight against restrictive reproductive legislation, please visit our Advocacy in Action Fund.

• Latest News
• Access to Care
• Advocacy
• Advocacy Resources

Public link

Please use the above public link if you want to share this noodl on another website.